Spiro George Rombotis Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

Spiro George Rombotis is President and CEO of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 68,658 shares of CYCC, which is worth approximately $25,403. The most recent transaction as insider was on Dec 21, 2023, when has been sold 6,070 shares (Common Stock) at a price of $3.31 per share, resulting in proceeds of $20,091. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.7K
0% 3M change
9.7% 12M change
Total Value Held $25,403

Spiro George Rombotis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2023
BUY
Open market or private purchase
$20,091 $3.31 p/Share
6,070 Added 8.12%
68,658 Common Stock
Jan 31 2023
BUY
Grant, award, or other acquisition
-
57,600 Added 47.92%
62,588 Common Stock
Nov 18 2021
BUY
Open market or private purchase
$18,000 $4.5 p/Share
4,000 Added 44.5%
4,988 Common Stock
SGR

Spiro George Rombotis

President and CEO
Berkeley Heights, NJ

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC